Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
Saved in:
| Title: | Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions. |
|---|---|
| Authors: | Pierre, Camille N.1,2 (AUTHOR), Adams, Lily E.3 (AUTHOR), Higgins, Jaclyn S.3 (AUTHOR), Anasti, Kara1,4 (AUTHOR), Goodman, Derrick1,5 (AUTHOR), Mielke, Dieter5 (AUTHOR), Stanfield-Oakley, Sherry5 (AUTHOR), Powers, John M.3,6 (AUTHOR), Li, Dapeng1,4 (AUTHOR), Rountree, Wes1,4 (AUTHOR), Wang, Yunfei1,4 (AUTHOR), Edwards, Robert J.1,4 (AUTHOR), Alam, S. Munir1,4 (AUTHOR), Ferrari, Guido1,5,7 (AUTHOR), Tomaras, Georgia D.1,5,7,8 (AUTHOR), Haynes, Barton F.1,4,8 (AUTHOR), Baric, Ralph S.6 (AUTHOR) rbaric@email.unc.edu, Saunders, Kevin O.1,5,7,8 (AUTHOR) rbaric@email.unc.edu |
| Source: | PLoS Pathogens. 6/20/2024, Vol. 20 Issue 6, p1-23. 23p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
